Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Maria Motta

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancers|November 25, 2023
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and PreventionBenedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Frontiers in Medicine|December 27, 2021
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune SystemPietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
International Journal of Molecular Sciences|September 13, 2025
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver BiomarkersPietro Torre, Benedetta Maria Motta, Tommaso Sarcina, et al.
Nutrients|April 13, 2024
Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging FrontiersMartina Lombardi, Jacopo Troisi, Benedetta Maria Motta, et al.
International Journal of Molecular Sciences|December 11, 2025
Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Benedetta Maria Motta, Alessandra Rosati, Mariano Festa, et al.
Internal and Emergency Medicine|May 16, 2024
Evaluating cardiovascular risk in metabolic steatosis with precision medicine non-invasive approaches: insights from a cohort studyMario Masarone, Benedetta Maria Motta, Pietro Torre, et al.
Journal of Hepatology|September 25, 2012
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosisLuca Valenti, Paola Dongiovanni, Marco Maggioni, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 14, 2011
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver diseaseLuca Valenti, Benedetta Maria Motta, Anna Alisi, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis BMauro Viganò, Luca Valenti, Pietro Lampertico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterationsLuca Valenti, Paola Dongiovanni, Benedetta Maria Motta, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancers|November 25, 2023
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and PreventionBenedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Frontiers in Medicine|December 27, 2021
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune SystemPietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
International Journal of Molecular Sciences|September 13, 2025
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver BiomarkersPietro Torre, Benedetta Maria Motta, Tommaso Sarcina, et al.
Nutrients|April 13, 2024
Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging FrontiersMartina Lombardi, Jacopo Troisi, Benedetta Maria Motta, et al.
International Journal of Molecular Sciences|December 11, 2025
Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Benedetta Maria Motta, Alessandra Rosati, Mariano Festa, et al.
Internal and Emergency Medicine|May 16, 2024
Evaluating cardiovascular risk in metabolic steatosis with precision medicine non-invasive approaches: insights from a cohort studyMario Masarone, Benedetta Maria Motta, Pietro Torre, et al.
Journal of Hepatology|September 25, 2012
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosisLuca Valenti, Paola Dongiovanni, Marco Maggioni, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 14, 2011
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver diseaseLuca Valenti, Benedetta Maria Motta, Anna Alisi, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis BMauro Viganò, Luca Valenti, Pietro Lampertico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterationsLuca Valenti, Paola Dongiovanni, Benedetta Maria Motta, et al.
Pageof 3